Josep M. Argimón

1.9k total citations
31 papers, 962 citations indexed

About

Josep M. Argimón is a scholar working on General Health Professions, Psychiatry and Mental health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Josep M. Argimón has authored 31 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in General Health Professions, 8 papers in Psychiatry and Mental health and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Josep M. Argimón's work include Dementia and Cognitive Impairment Research (8 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Sarcoidosis and Beryllium Toxicity Research (3 papers). Josep M. Argimón is often cited by papers focused on Dementia and Cognitive Impairment Research (8 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Sarcoidosis and Beryllium Toxicity Research (3 papers). Josep M. Argimón collaborates with scholars based in Spain, France and Sweden. Josep M. Argimón's co-authors include Gemma Flores‐Mateo, Catherine Reed, Richard Dodel, Anders Wimo, Giuseppe Bruno, Roy Jones, Bruno Vellas, Josep María Haro, Mark Belger and Josep Alfons Espinàs and has published in prestigious journals such as The American Journal of Medicine, Antimicrobial Agents and Chemotherapy and British Journal of Cancer.

In The Last Decade

Josep M. Argimón

31 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josep M. Argimón Spain 17 371 334 148 141 123 31 962
James C. Romeis United States 19 310 0.8× 156 0.5× 270 1.8× 140 1.0× 52 0.4× 51 1.1k
Olivier Saint‐Jean France 21 489 1.3× 175 0.5× 196 1.3× 163 1.2× 59 0.5× 76 1.3k
Kimberly K. Engelman United States 20 363 1.0× 170 0.5× 98 0.7× 144 1.0× 110 0.9× 48 1.1k
Meredith Wallace United States 13 266 0.7× 129 0.4× 82 0.6× 150 1.1× 88 0.7× 23 1.2k
Rhian Parham United Kingdom 9 189 0.5× 361 1.1× 154 1.0× 144 1.0× 39 0.3× 11 1.4k
Christine Walker Australia 22 358 1.0× 177 0.5× 99 0.7× 114 0.8× 39 0.3× 94 1.3k
Van L. Parsons United States 9 198 0.5× 91 0.3× 109 0.7× 129 0.9× 68 0.6× 25 919
Hugo M. Smeets Netherlands 20 161 0.4× 280 0.8× 85 0.6× 87 0.6× 62 0.5× 51 1.0k
M. Heins Netherlands 19 244 0.7× 196 0.6× 116 0.8× 200 1.4× 64 0.5× 72 1.0k
Michał Matyjaszczyk Poland 5 234 0.6× 469 1.4× 326 2.2× 102 0.7× 37 0.3× 6 2.1k

Countries citing papers authored by Josep M. Argimón

Since Specialization
Citations

This map shows the geographic impact of Josep M. Argimón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep M. Argimón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep M. Argimón more than expected).

Fields of papers citing papers by Josep M. Argimón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep M. Argimón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep M. Argimón. The network helps show where Josep M. Argimón may publish in the future.

Co-authorship network of co-authors of Josep M. Argimón

This figure shows the co-authorship network connecting the top 25 collaborators of Josep M. Argimón. A scholar is included among the top collaborators of Josep M. Argimón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep M. Argimón. Josep M. Argimón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coma, Ermengol, Leonardo Méndez-Boo, Núria Mora, et al.. (2021). Divergences on expected pneumonia cases during the COVID-19 epidemic in Catalonia: a time-series analysis of primary care electronic health records covering about 6 million people. BMC Infectious Diseases. 21(1). 283–283. 6 indexed citations
2.
Jones, Roy, Jérémie Lebrec, Kristin Kahle‐Wrobleski, et al.. (2017). Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes. Dementia and Geriatric Cognitive Disorders Extra. 7(1). 87–100. 32 indexed citations
3.
García‐Altés, Anna & Josep M. Argimón. (2016). La transparencia en la toma de decisiones de salud pública. Gaceta Sanitaria. 30. 9–13. 6 indexed citations
4.
Reed, Catherine, Mark Belger, Bruno Vellas, et al.. (2015). Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease. International Psychogeriatrics. 28(2). 247–259. 36 indexed citations
5.
Haro, Josep María, Kristin Kahle‐Wrobleski, Giuseppe Bruno, et al.. (2014). Analysis of burden in caregivers of people with Alzheimer's disease using self-report and supervision hours. The journal of nutrition health & aging. 18(7). 677–684. 81 indexed citations
6.
Wimo, Anders, Catherine Reed, Richard Dodel, et al.. (2013). The GERAS Study: A Prospective Observational Study of Costs and Resource Use in Community Dwellers with Alzheimer's Disease in Three European Countries – Study Design and Baseline Findings. Journal of Alzheimer s Disease. 36(2). 385–399. 127 indexed citations
7.
Gudiol, Francesc, et al.. (2012). The development and successful implementation of the VINCat Program. Enfermedades Infecciosas y Microbiología Clínica. 30. 3–6. 25 indexed citations
8.
Reed, Catherine, Josep M. Argimón, Mark Belger, et al.. (2012). PHS50 Health Care Resource Use and Cost in Alzheimer's Disease in Three European Countries – Baseline Findings of the GERAS Study. Value in Health. 15(7). A527–A527. 2 indexed citations
9.
Espinàs, Josep Alfons, Luisa Aliste, Esteve Fernández, et al.. (2011). Narrowing the Equity Gap: The Impact of Organized versus Opportunistic Cancer Screening in Catalonia (Spain). Journal of Medical Screening. 18(2). 87–90. 31 indexed citations
10.
Prades, Joan, Josep Alfons Espinàs, Rebeca Font, Josep M. Argimón, & Josep M. Borràs. (2011). Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods study. British Journal of Cancer. 105(6). 753–759. 70 indexed citations
11.
Bosch, Xavier, Antoni Curós, Josep M. Argimón, et al.. (2011). Modelo de intervención coronaria percutánea primaria en Cataluña. Revista Española de Cardiología Suplementos. 11. 51–60. 19 indexed citations
12.
Flores‐Mateo, Gemma & Josep M. Argimón. (2007). Evidence based practice in postgraduate healthcare education: A systematic review. BMC Health Services Research. 7(1). 119–119. 149 indexed citations
13.
Argimón, Josep M., Esther Limón Ramírez, Joan Vila, & Carmen Cabezas. (2005). Health-Related Quality-of-Life of Care-Givers as a Predictor of Nursing-Home Placement of Patients With Dementia. Alzheimer Disease & Associated Disorders. 19(1). 41–44. 63 indexed citations
14.
Mozas, Pablo, Graciela Reyes, Ana Cenarro, et al.. (2004). W14.348 Cardiovascular risk factors in a Spanish heterozygous FH cohort. Atherosclerosis Supplements. 5(1). 80–80. 1 indexed citations
15.
Argimón, Josep M.. (2004). Health-related quality of life in carers of patients with dementia. Family Practice. 21(4). 454–457. 66 indexed citations
16.
Argimón, Josep M.. (2002). El intervalo de confianza: algo más que un valor de significación estadística. Medicina Clínica. 118(10). 382–384. 9 indexed citations
17.
Salazar, Albert, Juan Mañá, Xavier Pintó, et al.. (2002). Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia. Clinica Chimica Acta. 320(1-2). 59–64. 31 indexed citations
18.
Salazar, Albert, Juan Mañá, Isabel Hurtado, et al.. (2000). Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis. Atherosclerosis. 152(2). 497–502. 34 indexed citations
19.
20.
Ribera, Miquel, et al.. (1995). Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma. The American Journal of Medicine. 99(5). 485–490. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James C. Romeis Breakdown of academic impact, for papers by Olivier Saint‐Jean Breakdown of academic impact, for papers by Kimberly K. Engelman Breakdown of academic impact, for papers by Meredith Wallace Breakdown of academic impact, for papers by Rhian Parham Breakdown of academic impact, for papers by Christine Walker Breakdown of academic impact, for papers by Van L. Parsons Breakdown of academic impact, for papers by Hugo M. Smeets Breakdown of academic impact, for papers by M. Heins Breakdown of academic impact, for papers by Michał Matyjaszczyk
Rankless by CCL
2026